Literature DB >> 14599985

Clinical epidemiological study on intrahepatic cholelithiasis: analysis of 8585 cases.

Xi-Gang Chen1, Jia-Qi Liu, Min-Hao Peng, Wen-Guang Wang, Ding-Hua Yang, De-Hong Hu, Da-Yun Liu, Jian-Nin Deng.   

Abstract

OBJECTIVE: To investigate the clinical epidemiology of intrahepatic cholelithiasis in Guangxi area, China.
METHODS: 8585 cases of cholelithiasis proved by surgery in a period of 19 years were analyzed retrospectively. Data were collected and analyzed by computer software package PEMS.
RESULTS: Cases of intrahepatic cholelithiasis accounted for more than one third of cases of cholelithiasis treated in the same period. The prevalence of intrahepatic cholelithiasis in farmers increased from 23.4% out of all cases with gallstone in 1981-1985 to 55.8% in 1991-1999. The constituent ratio of intrahepatic cholelithiasis in males was nearly the same in females. The peak prevalence age of patients with intrahepatic cholelithiasis ranged from 31 to 40 years, and the mortality was the highest among all bile stone cases.
CONCLUSION: Intrahepatic cholelithiasis is by no means a vanishing disease, especially in rural area.

Entities:  

Mesh:

Year:  2003        PMID: 14599985

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  3 in total

Review 1.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

2.  LPS increases MUC5AC by TACE/TGF-α/EGFR pathway in human intrahepatic biliary epithelial cell.

Authors:  Zipei Liu; Feng Tian; Xiaobin Feng; Yu He; Peng Jiang; Jianwei Li; Fei Guo; Xin Zhao; Hong Chang; Shuguang Wang
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

3.  Neutrophil elastase stimulates MUC5AC expression in human biliary epithelial cells: a possible pathway of PKC/Nox/ROS.

Authors:  Yu Tian; Min Li; Shuodong Wu; Duoliang Wang; Ben Sun; Junqing Xie; Hong Wang
Journal:  Arch Med Sci       Date:  2017-04-20       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.